>>> US Gapping down

Gapping down

In reaction to disappointing earnings/guidance: RLOC -18.9% (also downgraded to Equal Weight from Overweight at First Analysis Sec, downgraded to Sell from Hold at Craig Hallum ), DTLK -18.3%, AVNW -17.4%, WFM -17.4% (several analyst downgrades), AEGR -16.1%, ZU -15.4%, GNC -12.3%, FEYE -11.1% (also enters agreement to acquire nPulse Technologies; financial terms not disclosed), EXTR -10.9%, OCLR -9.8%, TRMB -9.4%, MZOR -8.6%, AOL -7.6%, FNGN -7%, (light volume), GRPN -6.5%, CNVR -6.4%, (light volume), PRGO -6.3%, EXTR -6.2% (also announces departure of COO), WBAI -5%, GWPH -4.4%, ( receives Investigational New Drug From FDA for Phase 2/3 clinical trial of Epidiolex in the treatment of Dravet Syndrome), TGA -4.4%, VE -3.6%, FTR-3.5%, SFUN -3.5%, ESRT -2.5%, (light volume), SSNI -2.1%, BID -1.4%, HSBC -1.1%, CHUY -0.8%, (light volume), MYGN -0.8%, ACAD -0.8%, CODE -0.3%.

Select metals/mining stocks trading lower: BHP -1.4%, BBL -1%, GOLD -0.9%, SLV -0.5%, GLD -0.4%.

Other news: SBRA -4.8% (prices 7 mln shares of common stock at $28.35), TFM -4.4% (following WFM results; downgraded to Underperform from Neutral at Sterne Agee ), SABR -3.3% (still checking), AMTD -1.5% ( SEC is considering investigating brokerages handling of retail orders, according to reports), ETFC -1.5% ( SEC is considering investigating brokerages handling of retail orders, according to reports), YPF -1.2% (Repsol SA plans to make $622 mln capital gain from YPF sale, according to reports), AZN -1% and PFE -0.8% (Pfizer has indicated that Asterzenca takeover would help science, according to reports), FNSR -0.9% (following OCLR results), LMT -0.3% (Lockheed Martin/Boeing (BA) partnership denial will not be expanded upon by Judge, according to reports), SHLD-0.2% (planning more store closures, according to reports).

Analyst comments: INFY -3.4% (downgraded to Sell from Neutral at UBS), MRK -0.9% (downgraded to Equal-Weight from Overweight at Morgan Stanley), MAR -0.7% (downgraded to Equal Weight from Overweight at Morgan Stanley), EBAY -0.4% (downgraded to Neutral from Buy at SunTrust).